Microbix Biosystems Inc T.MBX

Alternate Symbol(s): MBXBF

Healthcare Biotechnology

Microbix Biosystems Inc. develops and commercializes biological and technological solutions for human health and wellbeing. It enables the commercialization of diagnostic assays by making a range of critical ingredients and devices for the global diagnostics industry, notably antigens for immunoassays and its laboratory quality assessment products (QAPs) that support clinical lab proficiency testing, enable assay development and validation, or help ensure the quality of clinical diagnostic workflows. Its segments include development, manufacturing and sales of products relating to the medical diagnostics industry, namely antigens as test ingredients, quality assessment products to help ensure the accuracy of test workflows and viral transport medium to enable collection of patient test samples and, and development and commercialization of novel and proprietary products or technologies, such as Kinlytic. Its Kinlytic urokinase is a biologic thrombolytic drug used to treat blood clots.

TSX:MBX - Post by User

Microbix Biosystems Inc > New Press Release - Governments of Ontario and Canada Invest in Microbix

<< Previous

Bullboard Posts

Next >>

Comment by wizzdumbon Mar 20, 2023 11:42am

110 Views

Post# 35349009

RE:RE:New Press Release - Governments of Ontario and Canada Invest in Microbix

You aren't taking into account the major impact that automation in machinery, systems, and processes are going to have. This has been the focus of the majority of the work that has beeen going on for the last year and continues.

<< Previous

Bullboard Posts

Next >>

Understanding tax loss season and the “Santa Claus rally”